Icon

JAYPIRCA (NDA216059)- (50MG,100MG)

PIRTOBRUTINIB LOXO ONCOL
50MG,100MG
No No
2041-Sep-14 2028-Jan-27
None None
None No
JAYPIRCA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inh bitor.
0 0 0
Total Other Developers 2
Drugs with Suitability No
50MG ** ** - - -
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.